The results of two multicenter, open-label studies assessing efficacy, tolerability and safety of protiramer, a high molecular weight synthetic copolymeric mixture, in patients with relapsing-remitting multiple sclerosis. [electronic resource]
Producer: 20090413Description: 238-43 p. digitalISSN:- 1352-4585
- Adult
- Chemistry, Pharmaceutical
- Dose-Response Relationship, Drug
- Female
- Glatiramer Acetate
- Humans
- Immunosuppressive Agents -- administration & dosage
- Injections, Subcutaneous
- Male
- Molecular Weight
- Multiple Sclerosis, Relapsing-Remitting -- drug therapy
- Peptides -- administration & dosage
- Pilot Projects
- Treatment Outcome
No physical items for this record
Publication Type: Clinical Trial; Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.